Moderator: Edward Nabrinsky, MD, Hematology/Oncology Fellow, Advocate Lutheran General Hospital

Journal Articles:

  1. Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
  2. Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
Session date: 
11/30/2023 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit

Please login or register to take this course.